Search research articles
Contact Us
Filters
Showing results (41-50 of 112) with videos related to
Page
of 12
Sort By:
Experimental Cell Research
|
August 5, 2014
BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells
Mariarita Perri, Jeremy L Yap, Jianshi Yu, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
November 26, 2009
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
Steven Fletcher, Joel A Drewry, Vijay M Shahani, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 2019
Optimization of a small-molecule Lipid II binder
Jay Chauhan, Steven M Kwasny, Steven Fletcher, et al.
RSC Medicinal Chemistry
|
February 10, 2023
Discovery of <i>N</i>-sulfonylated aminosalicylic acids as dual MCL-1/BCL-xL inhibitors
Lijia Chen, Jay Chauhan, Jeremy L Yap, et al.
Tetrahedron Letters
|
June 10, 2014
Baeyer-Villiger Rearrangement of a Substituted Pyrrole by Oxone
Joseph P Y Kao, Sukumaran Muralidharan, Peter Y Zavalij, et al.
RSC Medicinal Chemistry
|
April 27, 2026
Lead optimization of <b>5jc21</b> (CG13250), a quinolin-2(1<i>H</i>)-one-based inhibitor of the BRD4 member of the bromodomain and extraterminal (BET) family of proteins
Jay Chauhan, Sarah Pogash, Makoto Yoshioka, et al.
Investigational New Drugs
|
June 13, 2026
Correction to: Prostate cancer cells' growth is decreased by novel MYC inhibitors
Bita Nickkholgh, Joseph McGrath, Sivanandane Sittadjody, et al.
Pharmaceutical Research
|
March 19, 2026
Evaluation of Mass Spectrometry Compatible Reagents for Determining Small Molecule Loading in Poly(lactic acid) Nanoparticles
Samuel A Krug, Andrea L Cottingham, Masahiro Iwamoto, et al.
ACS Pharmacology & Translational Science
|
November 21, 2022
Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge
Nhu Truong, Christopher C Goodis, Andrea L Cottingham, et al.
Drug Development Research
|
May 15, 2025
Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors
Alexandria M Chan, Christian Eberly, Brandon Drennen, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 112) with videos related to
Sort By:
Page
of 12
Experimental Cell Research
|
August 5, 2014
BCL-xL/MCL-1 inhibition and RARγ antagonism work cooperatively in human HL60 leukemia cells
Mariarita Perri, Jeremy L Yap, Jianshi Yu, et al.
Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire
|
November 26, 2009
Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein
Steven Fletcher, Joel A Drewry, Vijay M Shahani, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 26, 2019
Optimization of a small-molecule Lipid II binder
Jay Chauhan, Steven M Kwasny, Steven Fletcher, et al.
RSC Medicinal Chemistry
|
February 10, 2023
Discovery of <i>N</i>-sulfonylated aminosalicylic acids as dual MCL-1/BCL-xL inhibitors
Lijia Chen, Jay Chauhan, Jeremy L Yap, et al.
Tetrahedron Letters
|
June 10, 2014
Baeyer-Villiger Rearrangement of a Substituted Pyrrole by Oxone
Joseph P Y Kao, Sukumaran Muralidharan, Peter Y Zavalij, et al.
RSC Medicinal Chemistry
|
April 27, 2026
Lead optimization of <b>5jc21</b> (CG13250), a quinolin-2(1<i>H</i>)-one-based inhibitor of the BRD4 member of the bromodomain and extraterminal (BET) family of proteins
Jay Chauhan, Sarah Pogash, Makoto Yoshioka, et al.
Investigational New Drugs
|
June 13, 2026
Correction to: Prostate cancer cells' growth is decreased by novel MYC inhibitors
Bita Nickkholgh, Joseph McGrath, Sivanandane Sittadjody, et al.
Pharmaceutical Research
|
March 19, 2026
Evaluation of Mass Spectrometry Compatible Reagents for Determining Small Molecule Loading in Poly(lactic acid) Nanoparticles
Samuel A Krug, Andrea L Cottingham, Masahiro Iwamoto, et al.
ACS Pharmacology & Translational Science
|
November 21, 2022
Modified Suberoylanilide Hydroxamic Acid Reduced Drug-Associated Immune Cell Death and Organ Damage under Lipopolysaccharide Inflammatory Challenge
Nhu Truong, Christopher C Goodis, Andrea L Cottingham, et al.
Drug Development Research
|
May 15, 2025
Augmenting the Anti-Leukemic Activity of the BCL-2 Inhibitor Venetoclax Through Its Transformation Into Polypharmacologic Dual BCL-2/HDAC1 and Dual BCL-2/HDAC6 Inhibitors
Alexandria M Chan, Christian Eberly, Brandon Drennen, et al.
Page
of 12